Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationStem Cell TransplantationTransplantation ConditioningStem CellsGraft vs Host DiseaseHematologic NeoplasmsLeukapheresisGranulocyte Colony-Stimulating FactorBone Marrow TransplantationMelphalanAntigens, CD34Hematopoietic Stem CellsBlood Component RemovalGraft SurvivalCombined Modality TherapyCyclophosphamideTreatment OutcomeBusulfanCord Blood Stem Cell TransplantationMyeloablative AgonistsMultiple MyelomaTransplantation ChimeraAntineoplastic Combined Chemotherapy ProtocolsTissue DonorsRecurrenceLiver TransplantationRemission InductionLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingEtoposideHistocompatibilityWhole-Body IrradiationHistocompatibility TestingThiotepaTransplantation, IsogeneicPOEMS SyndromeImmunosuppressive AgentsDisease-Free SurvivalRetrospective StudiesHematopoiesisInfectionVidarabineLeukemiaSurvival RateKidney TransplantationAmyloidosisSalvage TherapySurvival AnalysisTime FactorsEmbryonic Stem CellsGraft vs Leukemia EffectIfosfamideBlood CellsCarmustineVincristineCytarabineLeukemia, Myeloid, AcuteHodgkin DiseaseMesenchymal Stem Cell TransplantationPlatelet CountAdult Stem CellsCytomegalovirus InfectionsAnemia, AplasticMyelodysplastic SyndromesBlood Cell CountLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphomaFollow-Up StudiesLymphocyte DepletionNeoplasmsCell TransplantationFatal OutcomeCytophagocytosisCyclosporineImmunosuppressionTransplantation ImmunologyHematologic DiseasesBone MarrowFeasibility StudiesHLA AntigensHeart TransplantationOpportunistic InfectionsPluripotent Stem CellsCell DifferentiationPrecursor Cell Lymphoblastic Leukemia-LymphomaHistiocytosis, Non-Langerhans-CellLivedo ReticularisImmunophenotypingDoxorubicinBlood DonorsLung TransplantationProspective StudiesRecombinant ProteinsBone Marrow PurgingStem Cell NichePrednisone